AbbVie Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
AbbVie Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2012 to Q2 2024.
  • AbbVie Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $9.2B, a 48.4% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $9.2B +$3B +48.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $9.07B +$3.27B +56.3% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $8.51B +$2.94B +52.8% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $7.09B +$1.71B +31.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $6.2B +$1.17B +23.1% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.8B +$717M +14.1% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $5.57B +$687M +14.1% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $5.38B +$635M +13.4% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $5.03B +$225M +4.68% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $5.08B +$291M +6.07% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $4.88B +$33M +0.68% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $4.75B +$811M +20.6% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $4.81B +$799M +19.9% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $4.79B +$2.15B +81.7% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $4.85B +$2.56B +112% Dec 31, 2020 10-K 2022-02-18
Q3 2020 $3.94B +$2.26B +135% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $4.01B +$2.42B +152% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $2.64B +$1.07B +68.3% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.29B +$1.08B +89.4% Dec 31, 2019 10-K 2021-02-19
Q3 2019 $1.68B +$734M +77.8% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $1.59B +$680M +74.8% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $1.57B +$664M +73.5% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $1.21B -$118M -8.9% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $943M -$384M -28.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $909M -$396M -30.3% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $903M -$360M -28.5% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $1.33B +$114M +9.41% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $1.33B -$223M -14.4% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $1.31B -$140M -9.69% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $1.26B -$65M -4.9% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $1.21B +$63M +5.48% Dec 31, 2016 10-K 2018-02-16
Q3 2016 $1.55B +$315M +25.5% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.45B +$264M +22.4% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $1.33B -$427M -24.3% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $1.15B -$331M -22.4% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $1.24B +$434M +54.2% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $1.18B +$386M +48.6% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $1.76B +$952M +119% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $1.48B +$713M +93% Dec 31, 2014 10-K 2016-02-19
Q3 2014 $801M -$349M -30.3% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $795M -$898M -53% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $803M -$912M -53.2% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $767M -$68M -8.14% Dec 31, 2013 10-K 2015-02-20
Q3 2013 $1.15B Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $1.69B Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $1.72B Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $835M Dec 31, 2012 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.